Jabillo, Albert S.

HRN: 24-54-84  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2024
CEFTRIAXONE 1G (VIAL)
02/08/2024
02/15/2024
IV
2g
Q24
Dm Foot
Waiting Final Action 
02/08/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/08/2024
02/15/2024
IV
600mg
Q8
DM Foot
Waiting Final Action 
02/13/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/13/2024
02/20/2024
IV INFUSION
4.5 Grams
Every 6 Hours
DM Foot, Wagner Class 2; DM Type 2 Uncontrolled
Waiting Final Action 
06/16/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/16/2024
06/23/2024
IV
4.5g
Q8
DM Foot
Waiting Final Action 
06/16/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/16/2024
06/23/2024
IV
600mg
Q6
DM Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: